Small Bowel Cancer

Regional Health is involved in small bowel cancer research trials. Below is more information about the purpose and who the physician (principal investigator) is for each trial. For more in-depth information on the research studies, click the blue name which will lead you to the U.S. National Institute of Health website or call (605) 755-2300.

RU0215021
A multicenter phase II study of pembrolizumab (MK-3475) in patients with advanced small bowel adenocarcinomas

 

To learn more, contact:
Regional Health
John T. Vucurevich Cancer Care Institute

(605) 755-2300

Principal Investigators
Michael Robinson, MD
Medical Oncology